DIN 02543532 — LITFULO 50 MG
LITFULO is a capsule of Ritlecitinib marketed by PFIZER CANADA ULC. The full Ritlecitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02543532
- Brand name
- LITFULO
- Active ingredient
- Ritlecitinib
- Strength
- 50 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Janus kinase 3 (JAK3) and TEC family kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.